Digestive Diseases and Sciences

, Volume 55, Issue 1, pp 94–100 | Cite as

Infection by CagA-Positive Helicobacter pylori Strains may Contribute to Alter the Sperm Quality of Men with Fertility Disorders and Increase the Systemic Levels of TNF-α

  • Giulia Collodel
  • Elena MorettiEmail author
  • Maria Stella Campagna
  • Serena Capitani
  • Cristina Lenzi
  • Natale Figura
Original Article


This study was aimed to address the possibility that Helicobacter pylori infection may play a detrimental role in semen quality of men with idiopathic infertility. Infection by H. pylori and by strains expressing CagA was determined in 80 male infertile patients by Western blotting and ELISA. Semen analysis was performed by light microscopy and transmission electron microscopy quantitatively elaborated (fertility index, immaturity, necrosis, and apoptosis percentages). Systemic levels of IL-6 and TNF-α were evaluated. Infertile patients infected with H. pylori showed a low sperm quality respective to uninfected patients. Particularly, in CagA-positive patients we observed a significant reduction in sperm motility and in the fertility index, while apoptosis and necrosis were increased. In these patients, the means of systemic TNF-α levels were higher than those of uninfected patients. The negative influence of CagA-positive H. pylori infection on sperm quality may help to understand the role of chronic infections in reproductive disorders.


H. pylori infection CagA Male idiopathic infertility Spermatozoa TEM TNF-α 



This work was supported in part by funds from the University of Siena P.A.R. 2006, “Role of Helicobacter pylori infection in the development of some autoimmune diseases, such as Hashimoto’s thyroiditis, Sjögren’s syndrome and systemic sclerosis” and P.A.R. 2005, “Morphological, biochemical and molecular studies of human spermatogenesis in a flogistic environment.”


  1. 1.
    Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–1271. doi: 10.1056/NEJM199405053301803.CrossRefPubMedGoogle Scholar
  2. 2.
    Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17:225–227. doi: 10.1097/00005176-199308000-00018.PubMedCrossRefGoogle Scholar
  3. 3.
    Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437–439. doi: 10.1136/hrt.71.5.437.CrossRefPubMedGoogle Scholar
  4. 4.
    Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol. 1996;34:685–686. doi: 10.1016/S0190-9622(96)80086-7.CrossRefPubMedGoogle Scholar
  5. 5.
    Gasbarrini A, Gabrielli M, Fiore G, et al. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia. 2000;20:561–565. doi: 10.1046/j.1468-2982.2000.00077.x.CrossRefPubMedGoogle Scholar
  6. 6.
    Franceschi F, Leo D, Fini L, et al. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis. 2005;37:301–308. doi: 10.1016/j.dld.2004.10.015.CrossRefPubMedGoogle Scholar
  7. 7.
    Franceschi F, Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol. 2007;21:325–334. doi: 10.1016/j.bpg.2006.10.003.CrossRefPubMedGoogle Scholar
  8. 8.
    Manolakis A, Kapsoritakis AN, Potamianos SP. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter. 2007;12:287–297. doi: 10.1111/j.1523-5378.2007.00511.x.CrossRefPubMedGoogle Scholar
  9. 9.
    Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 1991;101:437–445.PubMedGoogle Scholar
  10. 10.
    Appelmelk BJ, Simoons-Smit I, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun. 1996;64:2031–2040.PubMedGoogle Scholar
  11. 11.
    D’Elios MM, Bergman MP, Amedei A, Appelmelk BJ, Del Prete G. Helicobacter pylori and gastric autoimmunity. Microbes Infect. 2004;6:1395–1401. doi: 10.1016/j.micinf.2004.10.001.CrossRefPubMedGoogle Scholar
  12. 12.
    De Korwin JD. Does Helicobacter pylori infection play a role in extragastric diseases? Presse Med. 2008;37:525–534. doi: 10.1016/j.lpm.2007.07.029.CrossRefPubMedGoogle Scholar
  13. 13.
    Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull. 1998;54:139–150.PubMedGoogle Scholar
  14. 14.
    Figura N, Piomboni P, Ponzetto A, et al. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol. 2002;14:663–669. doi: 10.1097/00042737-200206000-00012.CrossRefPubMedGoogle Scholar
  15. 15.
    World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interactions. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 1999.Google Scholar
  16. 16.
    Baccetti B, Bernieri G, Burrini AG, et al. Notulae seminologicae. 5. Mathematical evaluation of interdependent submicroscopic sperm alterations. J Androl. 1995;16:356–371.PubMedGoogle Scholar
  17. 17.
    Collodel G, Moretti E. Morphology and meiotic segregation in spermatozoa from men of proven fertility. J Androl. 2008;29:106–114. doi: 10.2164/jandrol.107.002998.CrossRefPubMedGoogle Scholar
  18. 18.
    Graham DY, Osato MS, Olson CA, Zhang J, Figura N. Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestation of H. pylori infection. Helicobacter. 1998;3:174–178. doi: 10.1046/j.1523-5378.1998.08018.x.CrossRefPubMedGoogle Scholar
  19. 19.
    Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by CagA gene-positive Helicobacter pylori strains. Gut. 1997;41:442–451.PubMedGoogle Scholar
  20. 20.
    Kowalski M, Konturek PC, Pieniazek P, et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis. 2001;33:222–229. doi: 10.1016/S1590-8658(01)80711-8.CrossRefPubMedGoogle Scholar
  21. 21.
    Perdichizzi A, Nicoletti F, La Vignera S, et al. Effects of tumour necrosis factor-alpha on human sperm motility and apoptosis. J Clin Immunol. 2007;27:152–162. doi: 10.1007/s10875-007-9071-5.CrossRefPubMedGoogle Scholar
  22. 22.
    Shibata J, Goto H, Arisawa T, et al. Regulation of tumor necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut. 1999;45:24–31.PubMedGoogle Scholar
  23. 23.
    Russo F, Jirillo E, Clemente C, et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol. 2001;23:13–24. doi: 10.1081/IPH-100102563.CrossRefPubMedGoogle Scholar
  24. 24.
    Perri F, Clemante R, Festa V, et al. Serum tumour necrosis factor-alfa is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31:290–294.PubMedGoogle Scholar
  25. 25.
    Heidenreich A, Bonfig R, Wilbert DM, Strohmaier WL, Engelmann UH. Risk factors for antisperm antibodies in infertile men. Am J Reprod Immunol. 1994;31:69–76.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Giulia Collodel
    • 1
    • 2
  • Elena Moretti
    • 1
    • 2
    Email author
  • Maria Stella Campagna
    • 3
  • Serena Capitani
    • 2
    • 4
  • Cristina Lenzi
    • 3
  • Natale Figura
    • 3
  1. 1.Department of Biomedical Sciences, Applied Biology Section, Policlinico Le ScotteUniversity of SienaSienaItaly
  2. 2.Interdepartmental Centre for Research and Therapy of Male InfertilityUniversity of SienaSienaItaly
  3. 3.Department of Internal Medicine, Endocrine-Metabolic Sciences and BiochemistryUniversity of SienaSienaItaly
  4. 4.Department of Physiopathology, Experimental Medicine and Public HealthUniversity of SienaSienaItaly

Personalised recommendations